Search - tctmd.com

Displaying 901 - 920 of 1325

Sort: Relevancy | Date

News Daily News

VA Study Confirms Safety of PCI Without Surgical Backup

Todd Neale

October 03, 2014

News Daily News

Un Estudio de Veteranos Confirma la Seguridad de la PCI Sin Soporte Quirúrgico

Todd Neale

October 03, 2014

News Daily News

Majority of Stable CAD Patients Misunderstand Purpose of PCI

L.A. McKeown

October 03, 2014

News Daily News

La Prueba de la Isquemia Predice el Pronóstico de Pacientes Diabéticos con EAC Asintomática

Caitlin E. Cox

October 03, 2014

News Daily News

La Inmensa Mayoría de Pacientes con EAC Estable No Entienden el Propósito de una PCI

L.A. McKeown

October 03, 2014

News Daily News

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

Caitlin E. Cox

October 03, 2014

News Daily News

《2014年NSTE-ACS管理指南》有了新的标题和着重点

September 30, 2014

News Daily News

Las Directrices 2014 para el Manejo de SCASEST tienen un Nuevo Nombre y Objetivo

September 30, 2014

News Daily News

2014 Guideline for NSTE-ACS Management Has New Name, Focus

September 30, 2014

News Conference News TCT 2014

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Yael L. Maxwell

September 19, 2014

News Conference News TCT 2014

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

September 18, 2014

News Conference News TCT 2014

Microvascular Dysfunction Prevalent in Patients with Chest Pain, Non-Obstructive CAD

September 18, 2014

News Industry News

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

September 16, 2014

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Industry News

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

September 15, 2014

News Industry News

Neovasc Reducer™ Featured in Live Case Session at TCT 2014 Scientific Symposium

September 15, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

Advertisement

VA Study Confirms Safety of PCI Without Surgical Backup

Un Estudio de Veteranos Confirma la Seguridad de la PCI Sin Soporte Quirúrgico

Majority of Stable CAD Patients Misunderstand Purpose of PCI

La Prueba de la Isquemia Predice el Pronóstico de Pacientes Diabéticos con EAC Asintomática

La Inmensa Mayoría de Pacientes con EAC Estable No Entienden el Propósito de una PCI

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

《2014年NSTE-ACS管理指南》有了新的标题和着重点

Las Directrices 2014 para el Manejo de SCASEST tienen un Nuevo Nombre y Objetivo

2014 Guideline for NSTE-ACS Management Has New Name, Focus

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

Microvascular Dysfunction Prevalent in Patients with Chest Pain, Non-Obstructive CAD

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

Neovasc Reducer™ Featured in Live Case Session at TCT 2014 Scientific Symposium

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content